FNK:NSD-First Trust Mid Cap Value AlphaDEX Fund (USD)

ETF | Small Value | NASDAQ Global Market

Last Closing

USD 53.29

Change

0.00 (0.00)%

Market Cap

USD 0.05B

Volume

3.90K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the Nasdaq AlphaDEX(R) Mid Cap Value Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is designed to select value stocks from the NASDAQ US 600 Mid Cap Index (the "base index") that may generate positive alpha, or risk-adjusted returns, relative to traditional indices through the use of the AlphaDEX(R) selection methodology.

Inception Date: 19/04/2011

Primary Benchmark: NASDAQ AlphaDEX(R) Mid Cap Value TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.7%

Management Expense Ratio: 0.70 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
TLSI TriSalus Life Sciences Inc. 0.81 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-28 )

Largest Industry Peers for Small Value

Symbol Name Mer Price(Change) Market Cap
VTWV Vanguard Russell 2000 Value In.. 0.20 %

N/A

USD 0.83B
CSB VictoryShares US Small Cap Hig.. 0.35 %

N/A

USD 0.29B
FYT First Trust Small Cap Value Al.. 0.70 %

N/A

USD 0.16B

ETFs Containing FNK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Small Value) Market Performance vs. Exchange (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.49% 50% F 57% F
Dividend Return 1.14% 50% F 22% F
Total Return 5.63% 50% F 55% F
Trailing 12 Months  
Capital Gain 4.49% 50% F 57% F
Dividend Return 1.14% 50% F 22% F
Total Return 5.63% 50% F 55% F
Trailing 5 Years  
Capital Gain 48.15% 100% F 74% C
Dividend Return 9.36% 50% F 33% F
Total Return 57.51% 100% F 74% C
Average Annual (5 Year Horizon)  
Capital Gain 18.67% 100% F 72% C
Dividend Return 20.35% 100% F 73% C
Total Return 1.68% 50% F 43% F
Risk Return Profile  
Volatility (Standard Deviation) 27.53% 100% F 66% D+
Risk Adjusted Return 73.93% 100% F 89% A-
Market Capitalization 0.05B 50% F 50% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.